Biphenotypic Acute Leukemia: Description of a Case and Literature Review
Published: 2023-02-03
Page: 38-43
Issue: 2023 - Volume 6 [Issue 1]
S. A. Touré
*
Hematology Department, National Blood Transfusion Center of Dakar, Dakar, Senegal.
M. Keita
Hematology Department, National Blood Transfusion Center of Dakar, Dakar, Senegal.
M. Seck
Hematology Department, National Blood Transfusion Center of Dakar, Dakar, Senegal.
A. B. Diallo
Hematology Department, National Blood Transfusion Center of Dakar, Dakar, Senegal.
S. M. Gueye
Hematology Department, National Blood Transfusion Center of Dakar, Dakar, Senegal.
M. Traoré
Hematology Department, National Blood Transfusion Center of Dakar, Dakar, Senegal.
C. Koba
Hematology Department, National Blood Transfusion Center of Dakar, Dakar, Senegal.
Dissongo I
Hematology Department, National Blood Transfusion Center of Dakar, Dakar, Senegal.
E. Motassi
Hematology Department, National Blood Transfusion Center of Dakar, Dakar, Senegal.
F. Dieng
Hematology Department, National Blood Transfusion Center of Dakar, Dakar, Senegal.
B. F. Faye
Hematology Department, National Blood Transfusion Center of Dakar, Dakar, Senegal.
A. Sall
Hematology Laboratory, Dalal Jaam Hospital, Dakar, Senegal.
S. Diop
Hematology Department, National Blood Transfusion Center of Dakar, Dakar, Senegal.
*Author to whom correspondence should be addressed.
Abstract
Introduction: "Ambiguous lineage acute leukemias" including biphenotypic acute leukemia are subtypes of acute leukemia (AL) generally representing less than 5% of all acute leukemias. We report a case of biphenotypic acute leukemia (T and B) diagnosed in the clinical hematology department of Dakar.
Observation: This was a 17-year-old female patient, with no specific pathological history, referred for exploration of a bicytopenia associated with hyperleukocytosis that appeared 2 months before. The clinical examination showed an alteration of general state of health (PS WHO 3), an anemic syndrome, a sepsis with a pulmonary focus and a tumor syndrome (nodes and splenomegaly). The blood count showed a hyperleukocytosis of 94.15 G/L, an anemia of 3.7 g/dl normochromic normocytic aregenerative and a thrombocytopenia of 14 G/L. The blood smear showed 34% of blasts cells. The myelogram study showed an acute lymphoblastic leukemia. Immunophenotyping revealed partly T-type blasts (CyCD3+; sCD3-; CD7+; heterogeneous CD2 and CD5), B cells (CD19+ and CD79a+) and absence of aberrant myeloid markers. Replacement therapy with blood products (red blood cells and platelets concentrates) was provided to the patient. The short-term evolution was marked by a worsening of the clinical presentation and a mortality at day 3 of hospitalization.
Conclusion: Bi-phenotypic acute leukemia is a very rare cytological entity with a poor prognosis. Systematization of flow cytometry in our countries with limited resources would help to better diagnose AL.
Keywords: Acute leukemia, biphenotypic, flow cytometry
How to Cite
Downloads
References
Khalidi HS, Chang KL, Medeiros LJ, Brynes RK, Slovak ML, Murata-Collins JL, et al. Acute Lymphoblastic Leukemia: Survey of Immunophenotype, French-American-British Classification, Frequency of Myeloid Antigen Expression, and Karyotypic Abnormalities in 210 Pediatric and Adult Cases. Am J Clin Pathol. 1999; 111(4):467‑476. DOI:10.1093/ajcp/111.4.467
Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA. The Immunophenotype of Adult Acute Myeloid Leukemia: High Frequency of Lymphoid Antigen Expression and Comparison of Immunophenotype, French-American-British Classification, and Karyotypic Abnormalities. Am J Clin Pathol. 2022; 109(2):211‑220.
DOI:10.1093/ajcp/109.2.211
Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937-51. DOI:10.1182/blood-2009-03-209262
Campana D, Behm FG. Immunophenotyping of leukemia. J Immunol Methods. 2000;243(1‑2):59‑75. doi:10.1016/s0022-1759(00)00228-3
Bain BJ, Barnett D, Linch D, Matutes E, Reilly JT. Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders: Guidelines. Clin Lab Haematol. 2002;24 (1):1‑13. DOI:10.1046/j.1365-2257.2002.00135.x
Carbonell F, Swansbury J, Min T, Matutes E, Farahat N, Buccheri V, et al. Cytogenetic findings in acute biphenotypic leukaemia. Leukemia. 1996;10(8): 1283‑1287.
Hanson CA, Abaza M, Sheldon S,Ross CW, Schnitzer B, Stoolman LM. Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis. Br J Haematol. 1993;84(1): 49‑60. DOI:10.1111/j.1365-2141.1993.tb03024.x
Legrand O, Perrot J, Simonin G, Baudard M, Cadiou M, Blanc C, et al. Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P‐glycoprotein over‐expression. Br J Haematol. 1998;100(1):147‑155. doi:10.1046/j.1365-2141.1998.00523.x
Matutes E, Morilla R, Farahat N, Carbonell F, Swansbury J, Dyer M, et al. Definition of acute biphenotypic leukemia. Haematologica. 1997;82(1):64‑66.
Killick S, Matutes E, Powles RL, Hamblin M, Swansbury J, Treleaven JG, et al. Outcome of biphenotypic acute leukemia. Haematologica. 1999;84(8):699‑706.
Medinger M, Heim D, Lengerke C, Halter JP, Passweg JR. Akute Lymphoblastische Leukämie – Diagnostik und Therapie. Ther Umsch. 2019;76(9):510‑515. DOI:10.1024/0040-5930/a001127
Weinberg OK, Arber DA. Mixed-phenotype acute leukemia: historical overview and a new definition. Leukemia. 2010;24(11): 1844‑1851. DOI:10.1038/leu.2010.202
Bar M, Tong W, Othus M, Loeb KR, Estey EH. Central Nervous System Involvement in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2015;21(3):546‑551. DOI:10.1016/j.bbmt.2014.11.683
Lazarus HM, Richards SM, Chopra R, Litzow MR, Burnett AK, Wiernik PH, et al. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993. Blood.2006;108(2):465‑472. DOI:10.1182/blood-2005-11-4666
Xavier Troussard, Nabil Maarouf. Leucémies biphénotypiques (BAL) : mythe, réalité, perspectives. Spectra Biologie. 2006;25 N°152 : 34-38.
Baruchel A, Cayuela JM, Ballerini P, Landman-Parker J, Cezard V, Firat H, et al. The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcripts. Br J Haematol. 1997;99(1):101‑106. DOI:10.1046/j.1365-2141.1997.3603174.x
Dunphy CH, Batanian JR. Biphenotypic Hematological Malignancy with T-Lymphoid and Myeloid Differentiation. Cancer Genet Cytogenet. 1999;114(1): 51‑57. DOI:10.1016/s0165-4608(99)00037-0
Matutes E, Pickl WF, Van’t Veer M, Morilla R, Swansbury J, Strobl H, et al. Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood. 2011;117(11): 3163‑3171. DOI:10.1182/blood-2010-10-314682
Wolach O, Stone RM. How I treat mixed-phenotype acute leukemia. Blood. 2015; 125(16):2477‑2485. DOI:10.1182/blood-2014-10-551465
Xu X-Q, Wang J-M, Lu S-Q, Chen L, Yang J-M, Zhang W-P, et al. Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: A case series of a Chinese population. Haematologica. 2009;94(7):919‑927. DOI:10.3324/haematol.2008.003202
Rubnitz JE, Onciu M, Pounds S, Shurtleff S, Cao X, Raimondi SC, et al. Acute mixed lineage leukemia in children: the experience of St Jude Children’s Research Hospital. Blood. 2009;113(21): 5083‑5089.
DOI:10.1182/blood-2008-10-187351